title: [Use of Verapamil and Dilthiasem in treating patients at high cardiovascular risk (review of literature)].
abstract: The article deals with usage of nondihydropiridine calcium antagonists--verapamil and dilthiasem--in treating patients with arterial hypertension, cardiomyopathy and arrhythmia, for secondary prevention of IHD. Data also concern cardio-, angio--and nephroprotective activity of the medications, their ability to prevent left ventricle hypertrophy, possible usage in patients after myocardial infarction. The authors also discuss problems of tolerance and safety of calcium antagonists with prolonged action vs. those with short-term action.
authors.forename: G A
authors.initials: GA
authors.lastname: Baryshnikova
authors.forename: S A
authors.initials: SA
authors.lastname: Chorbinskayva
authors.forename: I I
authors.initials: II
authors.lastname: Stepanova
authors.forename: O E
authors.initials: OE
authors.lastname: Blochina
authors.forename: I V
authors.initials: IV
authors.lastname: Zverkov
authors.forename: L V
authors.initials: LV
authors.lastname: Maslovskyi
authors.forename: N B
authors.initials: NB
authors.lastname: Korchazhkina
authors.forename: O M
authors.initials: OM
authors.lastname: Maslennikova
mesh_terms: D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D004110:Diltiazem / Q000627:therapeutic use*; D006801:Humans; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D002121:Calcium Channel Blockers; D014700:Verapamil; D004110:Diltiazem